Refining the biomanufacturing of microalgae-derived extracellular vesicles as a potential nanotherapeutic for osteoarthritis
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 16.04.2026. Verfasst von Meng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative joint disease characterized by oxidative stress, chronic inflammation and progressive cartilage degradation. Current treatments remain largely symptomatic and fail to target underlying disease mechanisms. Extracellular vesicles (EVs) have emerged as promising nanotherapeutics; however, mammalian-derived EVs face limitations related to cost, scalability and manufacturing complexity. Microalgae represent a sustainable alternative, yet their potential as EV biofactories for regenerative medicine remains largely unexplored. This study investigates the biomanufacturing and therapeutic potential of microalgae-derived EVs for OA. Four microalgae species (Chlorella sorokiniana, Synechococcus sp., Leptolyngbya sp. and Chlamydomonas reinhardtii CC1690) were cultured under varying photoperiods (0, 16 and 24 h light/day) to evaluate effects on viability, growth and EV production. EVs were characterized using transmission electron microscopy, nanoparticle tracking analysis, protein quantification and immunoblotting. Antioxidant activity and therapeutic efficacy were assessed in a cytokine-induced OA-like in vitro model. All species maintained high viability (>80%), with EV yield strongly dependent on light exposure. Leptolyngbya sp. demonstrated the fastest growth and highest EV production under extended illumination, generating EVs with antioxidant properties. Leptolyngbya-derived EVs enhanced mesenchymal stromal cell proliferation and migration and mitigated cytokine-induced matrix degradation. These findings establish Leptolyngbya as a scalable, cost-effective source of therapeutic EVs for OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands.
- Regenerative Medicine Center Utrecht, University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands.
- Department of Oral and Maxillofacial Surgery & Special Dental Care, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands.
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands.
ORCID-Profile: Kenny Man
Förderung
- China Scholarship Council
Zitieren
APA
Wang, M., Gil Izquierdo, S., Kara Özenler, A., Rios, J. L., de Ruijter, M., Gawlitta, D., Malda, J., & Man, K. (2026). Refining the biomanufacturing of microalgae-derived extracellular vesicles as a potential nanotherapeutic for osteoarthritis. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag074
Vancouver
Wang M, Gil Izquierdo S, Kara Özenler A, Rios JL, de Ruijter M, Gawlitta D, et al. Refining the biomanufacturing of microalgae-derived extracellular vesicles as a potential nanotherapeutic for osteoarthritis. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag074
BibTeX
@article{Wang2026,
author = {Wang, Meng and Gil Izquierdo, Sara and Kara Özenler, Aylin and Rios, Jaqueline Lourdes and de Ruijter, Mylène and Gawlitta, Debby and Malda, Jos and Man, Kenny},
title = {Refining the biomanufacturing of microalgae-derived extracellular vesicles as a potential nanotherapeutic for osteoarthritis},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag074}
}
EUVIMED